Page 5 - Self Administration News Today

Zilucoplan is the first once-daily, subcutaneous, self-administered, targeted C5 complement inhibitor for adults with gMG who are AChR antibody positive.

Data published in Neuropharmacology shows mGlu2 PAMs attenuate oxycodone use and potential as a novel treatment for opioid use disorder Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 24, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced data showing that administration of a metabotropic glutamate 2 (mGlu2) positive allosteric modulator significantly

We have people taking two or three different injectable drugs every other week.

Analysis in English on Syrian Arab Republic and 1 other country about Peacekeeping and Peacebuilding, Protection and Human Rights, Earthquake and more; published on 10 May 2023 by iMMAP

The following is the Congressional Research Service Feb. 24, 2023, In Focus report: Syria and U.S. Policy. From the report Since 2011, conflict between the government of Syrian President Bashar al Asad and opposition forces seeking his removal has displaced roughly half of the country’s population and killed over half a million people. Five countries […]

An online tool can help patients diagnosis and treat an episode of recurrent benign paroxysmal positional vertigo on their own.

Green light for new asthma pen which offers self-administration option across the EU - News - PharmaTimes

Recent Turkish airstrikes and shelling damaged oil fields and power plants in SDF-held northeastern Syria, threatening a prolonged energy crisis and exacerb ...

  Companies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data.FRANKLIN LAKES, N.J., October 18, 2022 / B3C newswire / -- BD (Becton, Dickinson and Compan...

The preparation of the common loop diuretic is said to provide "intravenous-equivalent" dosing for outpatients with heart failure and volume overload.